Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ascent Pediatrics

1989 FOUNDED
M&A STATUS
61-70 EMPLOYEES
M&A LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Manufacturer of drugs for the pediatric pharmaceutical companies specializing in treatment of asthma in children. The company's drugs are designed to improve upon common pediatric illness such as anti-infectives, bronchodilators, antipyretics, analgesics, cough and cold approved for children with chronic ailments.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 187 Ballardvale Street
  • Suite B125
  • Wilmington, MA 01887
  • United States

Ascent Pediatrics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ascent Pediatrics‘s full profile, request access.

Request full access to PitchBook

Ascent Pediatrics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ascent Pediatrics‘s full profile, request access.

Request full access to PitchBook